Israel Abebrese Sefah is Specialist Pharmacist with keen interest in infectious diseases and cardiovascular disorders who works as a lecturer at the Department of Pharmacy Practice in the School of Pharmacy of the University of Health and Allied Sciences, Ho in the Volta Region of Ghana.
Education
He holds a fellowship in clinical pharmacy which he obtained from the West African Postgraduate College of Pharmacist, Ghana branch in 2017 and Master of Public Health which he obtained in 2018 at the Ensign College located at Kpong in the Eastern Region of Ghana. He has vast academic qualifications such as Graduate Diploma in Purchasing and Supply (UK in 2016), Foundational Diploma in Purchasing and Supply (UK in 2015) and Certificates in Project Management in Global Health (April, 2019), Epidemiology (April, 2019) and Leadership and Management in Health (November, 2018) all from the University of Washington, USA.
Work experience
Mr. Sefah is an experienced Specialist Pharmacist with over ten years of clinical experience working both as a hospital pharmacist, at Ho Teaching Hospital and then at Keta Municipal Hospital as the Head of the Pharmacy Department, and as A community pharmacist. While at Keta Municipal Hospital, he chaired the Hospital Quality Improvement Team that conducted several quality improvement projects including reducing maternal mortality through improvement in the management of shock (2019), reducing anemia in pregnancy by 36 weeks of gestation (2018) and reducing surgical site wound infection (2017). Prior to his appointment he was the managing director of a retail and wholesale community pharmacy located in the Keta Municipality.
Research output
Mr. Sefah’s research interest spans from the area of outcome research in Pharmaceutical Care of infectious diseases and non-communicable diseases in lower and middle income countries. These types of researches seek to study the structures and processes of pharmaceutical care to provide evidence about which interventions work best and for which types of patients and under what circumstances in LMIC which is grappling with the double burden of diseases.